•
Jun 30, 2023

Stoke Therapeutics Q2 2023 Earnings Report

Total Revenue
-$2.48M
Previous year: $3.23M
-176.8%
EPS
-$0.69
Previous year: -$0.63
+9.5%
Gross Profit
-$3.65M
Previous year: $2.4M
-252.3%
Cash and Equivalents
$192M
Previous year: $67.8M
+183.5%
Free Cash Flow
-$22.6M
Previous year: -$20.6M
+9.8%
Total Assets
$257M
Previous year: $301M
-14.8%

Stoke Therapeutics

Stoke Therapeutics